AU2727400A - Moxonidine salts - Google Patents

Moxonidine salts

Info

Publication number
AU2727400A
AU2727400A AU27274/00A AU2727400A AU2727400A AU 2727400 A AU2727400 A AU 2727400A AU 27274/00 A AU27274/00 A AU 27274/00A AU 2727400 A AU2727400 A AU 2727400A AU 2727400 A AU2727400 A AU 2727400A
Authority
AU
Australia
Prior art keywords
moxonidine
salts
moxonidine salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27274/00A
Inventor
Neil Robert Anderson
David Dale Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2727400A publication Critical patent/AU2727400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU27274/00A 1999-01-29 2000-01-14 Moxonidine salts Abandoned AU2727400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11798199P 1999-01-29 1999-01-29
US60117981 1999-01-29
PCT/US2000/000968 WO2000044355A1 (en) 1999-01-29 2000-01-14 Moxonidine salts

Publications (1)

Publication Number Publication Date
AU2727400A true AU2727400A (en) 2000-08-18

Family

ID=22375851

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27274/00A Abandoned AU2727400A (en) 1999-01-29 2000-01-14 Moxonidine salts

Country Status (2)

Country Link
AU (1) AU2727400A (en)
WO (1) WO2000044355A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020198210A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Alpha-2-adrenergic agonist/fatty acid compositions
WO2002089853A2 (en) * 2001-05-03 2002-11-14 Allergan, Inc. Compositions having enhanced pharmacokinetic characteristics
US20020198209A1 (en) 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
ATE487712T1 (en) * 2006-08-31 2010-11-15 Chemagis Ltd USE OF MONOXIDINE SALTS TO PURIFY MONOXIDINE
WO2008144399A1 (en) * 2007-05-18 2008-11-27 Bausch & Lomb Incorporated COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (en) * 1987-11-24 1989-06-08 Beiersdorf Ag PHARMACEUTICAL PRAEPARATE
DE4423177A1 (en) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglycemic drugs
US5977121A (en) * 1995-02-28 1999-11-02 Eli Lilly And Company Use of moxonidine for the treatment of atherosclerosis
EP0914128A1 (en) * 1996-06-06 1999-05-12 Eli Lilly And Company Formulation and method for treating congestive heart failure
NO980546L (en) * 1997-02-11 1998-08-12 Lilly Co Eli Pharmaceuticals
DE19722322A1 (en) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephro-protective drug

Also Published As

Publication number Publication date
WO2000044355A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
AU5413600A (en) Compounds
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU4556700A (en) Pyrimidine compounds
AU5967600A (en) Candystraw
AU1746401A (en) Compounds
AU3997700A (en) Anti-first-pass effect compounds
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU6440900A (en) Homogentisate-dioxygenase
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU2727400A (en) Moxonidine salts
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU7303400A (en) Osseo-distractor
AU7513400A (en) Hydantoin-racemase
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine
AU1915601A (en) Periotome
AU5119400A (en) Compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase